Approval · Notice of Compliance 11516 · 2010
CEFA-DRI: Notice of Compliance 11516
Issued June 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11516
- Date
- June 16, 2010
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-DRI | 02173255 | Marketed |
Medicinal ingredients
- CEPHAPIRIN BENZATHINE 300 MG per 10ML